The factor XIII‐A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations-Reference-Cited by-同舟云学术

The factor XIII‐A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations

Published:2020-04 Issue:4 Volume:18 Page:885-894
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Kattula Sravya¹,Bagoly Zsuzsa²³^ORCID,Tóth Noémi Klára²,Muszbek László²^ORCID,Wolberg Alisa S.¹^ORCID

Affiliation:

1. Department of Pathology and Laboratory Medicine and UNC Blood Research Center University of North Carolina at Chapel Hill Chapel Hill NC USA

2. Division of Clinical Laboratory Science Department of Laboratory Medicine Faculty of Medicine University of Debrecen Debrecen Hungary

3. MTA‐DE Cerebrovascular and Neurodegenerative Research Group University of Debrecen Debrecen Hungary

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14744

Reference39 articles.

1. The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits

2. Factor XIII: novel structural and functional aspects

3. Rheological properties of fibrin clots. Effects of fibrinogen concentration, factor XIII deficiency, and factor XIII inhibition;Glover CJ;J Lab Clin Med,1975

4. The antifibrinolytic function of factor XIII is exclusively expressed through α2-antiplasmin cross-linking

5. Human Procarboxypeptidase U, or Thrombin-activable Fibrinolysis Inhibitor, Is a Substrate for Transglutaminases

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of the lipid status and indicators of hemostasis among young men of different ethnic groups to assess thrombogenic risk;Сибирский научный медицинский журнал;2024-04-26

2. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc;Haematologica;2023-12-07

3. Fibrinogen and fibrin: synthesis, structure, and function in health and disease;Journal of Thrombosis and Haemostasis;2023-11

4. An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis;International Journal of Molecular Sciences;2023-04-28

5. Transglutaminase Activities of Blood Coagulant Factor XIII Are Dependent on the Activation Pathways and on the Substrates;Thrombosis and Haemostasis;2022-12-06